Côd QR

A phase 2 study of panobinostat with lenalidomide and weekly dexamethasone in myeloma

Abstract: Phase 3 studies combining histone deacetylase inhibitors with bortezomib were hampered by gastrointestinal (GI) intolerance, which was not observed when combined with immunomodulatory drugs. This study is a single-center phase 2 study of panobinostat with lenalidomide and dexamethasone (FR...

Disgrifiad llawn

Wedi'i Gadw mewn:
Prif Awduron: Ajai Chari, Hearn J. Cho, Amishi Dhadwal, Gillian Morgan, Lisa La, Katarzyna Zarychta, Donna Catamero, Erika Florendo, Nadege Stevens, Daniel Verina, Elaine Chan, Violetta Leshchenko, Alessandro Laganà, Deepak Perumal, Anna Huo-Chang Mei, Kaity Tung, Jami Fukui, Sundar Jagannath, Samir Parekh
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Elsevier 2017-08-01
Cyfres:Blood Advances
Mynediad Ar-lein:http://www.sciencedirect.com/science/article/pii/S2473952920302962
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg